Physician

Alan W Goldfeder, M.D.

According to 2025 Medicare claims, Alan Goldfeder, M.D. (NPI: 1841256757) practices ophthalmology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Somerset, NJ. This provider's primary affiliated billing organization is THE EYE CLINIC NJ (NPI: 1467539791; TIN: 221967012) and primary practice location at 07083-5718.

Goldfeder's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 227 traditional Medicare patients, billed 857 HCPCS/CPT codes, and received $37,330 in Medicare payments. 2024 Part D data shows 145 prescription claims across 53 beneficiaries totaling $13,087 in drug costs, led by Brimonidine Tartrate (Brimonidine Tartrate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $265,504 to $37,330. Similarly, Part D prescription costs have declined steadily, from $210,366 to $13,087. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	582	4,488	$265,504
2016	556	3,676	$193,235
2017	517	3,339	$152,323
2018	458	3,081	$139,437
2019	399	2,609	$119,282
2020	271	1,349	$65,092
2021	278	1,420	$75,859
2022	302	1,432	$76,595
2023	227	857	$37,330
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	260	1,596	$210,366
2016	252	1,539	$222,791
2017	279	1,488	$244,251
2018	276	1,459	$235,155
2019	283	1,604	$254,357
2020	222	1,450	$224,641
2021	195	1,148	$177,470
2022	186	1,091	$174,724
2023	173	1,017	$146,767
2024	53	145	$13,087

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brimonidine Tartrate	Brimonidine Tartrate	33	2,090	$2,373
Latanoprost	Latanoprost	62	3,657	$605
Timolol Maleate	Timolol Maleate	12	975	$219

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alan W. Goldfeder, M.D.?

Tedicare shows public-source Medicare data for Alan W. Goldfeder, M.D. (NPI 1841256757), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan W. Goldfeder, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan W. Goldfeder, M.D.?

Alan W. Goldfeder, M.D. is linked to THE EYE CLINIC NJ (billing NPI 1467539791) in the available physician profile data.

Does Alan W. Goldfeder, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.